Delivery Order SPE2DR25D3304-SPE2DR26F48L7
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for 2,800 BAU sublingual tablets of GRASTEK in 30-count packaging. This competitively awarded, firm fixed-price delivery order, valued at $2,563.18, was issued on June 20, 2025, with an ultimate completion date of June 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $1,241.75 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 2,800 units of Grastek 2,800 BAU SL Tablet 30s. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by November 30, 2023. No set-aside designation was applied to this award made under the prime vendor's existing pharmaceutical distribution...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order from the Defense Logistics Agency (DLA) valued at $1,450.71. The contract is for the delivery of 4567692576 Allergy Relief 180 mg Tablets. It is a firm-fixed price contract with a completion date of March 26, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of allergy relief tablets, specifically "ALLERGY RELIEF 180 MG TABLET 30S," with a ceiling value of $3,878.10. This is a firm fixed-price delivery order contract with a completion date of June 4, 2025. The contract is not set aside and represents an open competition....
- The Defense Logistics Agency awarded a delivery order valued at $1,045.16 to AmerisourceBergen Drug Corp for the supply of levocetirizine 5 mg tablets (90-count units) on November 7, 2025, with completion targeted for November 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Allergy Relief 180 mg tablets, with a total ceiling value of $1,730.40 and a period of performance through January 21, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award is for the delivery of ALLERGY RELIEF 180 MG TABLET 30S to the Defense Logistics Agency (DLA). The $1,384.32 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 13, 2025. There was no set-aside designation indicated for this contract. Amerisourcebergen Drug Corp holds a $999,999,999...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,394.77 for 500 tablets of Cetirizine HCL 10 mg on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,698.47 to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Cetirizine-Pseudoephedrine ER 5-120 mg tablets in quantities of 12 units. The contract, designated as non-set-aside and utilizing firm fixed-price terms, is scheduled for completion by December 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count packages) with a ceiling value of $5,565.77. This is a firm fixed-price delivery order executed under a non-set-aside competitive procurement, with an ultimate completion date of December 17, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate office...
- SPE2DR25D3304Indefinite Delivery Contract
- SPE2DR25D3304-SPE2DR26F48L7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (subsidiary of Cencora, Inc.) on January 16, 2026, for $1,487.94 to supply 30 tablets of Grastek 2,800 Biological Allergen Units sublingual tablets. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by January 20, 2026, with performance at the company's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This delivery order is issued under AmerisourceBergen's substantial $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen maintains a comprehensive portfolio of federal medical supply contracts across multiple therapeutic domains, supporting critical medical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Grastek product supplied under this order is an allergen immunotherapy tablet used for treating allergic rhinitis, representing one of many specialized pharmaceutical commodities the contractor delivers through its federal contract awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/15/26 |